Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission.
about
Elk-1 a transcription factor with multiple facets in the brainAntidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa LCannabis and psychosis/schizophrenia: human studiesStriatal signal transduction and drug addictionERK1/2 antagonizes glycogen synthase kinase-3beta-induced apoptosis in cortical neuronsNuclear RNA-seq of single neurons reveals molecular signatures of activationCB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice.Role of the ERK pathway in psychostimulant-induced locomotor sensitization.Effects of the MEK inhibitor, SL-327, on rewarding, motor- and cellular-activating effects of D-amphetamine and SKF-82958, and their augmentation by food restriction in rat.Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatumELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers.The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ anInhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preferenceInhibition of extracellular signal-regulated kinase (ERK) activity with SL327 does not prevent acquisition, expression, and extinction of ethanol-seeking behavior in mice.Protein kinases and addiction.Microbial infections, immunomodulation, and drugs of abuse.Alcohol alters the activation of ERK1/2, a functional regulator of binge alcohol drinking in adult C57BL/6J mice.The dual neuroprotective-neurotoxic profile of cannabinoid drugs.Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling.Differential modulation of brainstem phosphatidylinositol 3-kinase/Akt and extracellular signal-regulated kinase 1/2 signaling underlies WIN55,212-2 centrally mediated pressor response in conscious rats.Intra-amygdala inhibition of ERK(1/2) potentiates the discriminative stimulus effects of alcohol.The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness.Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitriteThe endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism.Analysis of transcriptional responses in the mouse dorsal striatum following acute 3,4-methylenedioxymethamphetamine (ecstasy): identification of extracellular signal-regulated kinase-controlled genes.Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (Δ⁹-THC) in adult female rats.Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling.Prefrontal microRNA-221 Mediates Environmental Enrichment-Induced Increase of Locomotor Sensitivity to NicotineNeuroplasticity in brain reward circuitry following a history of ethanol dependence.The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humansMolecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects.Cannabinoid conditioned reward and aversion: behavioral and neural processes.Signaling from the cytoplasm to the nucleus in striatal medium-sized spiny neuronsCannabinoids for the treatment of schizophrenia? A balanced neurochemical framework for both adverse and therapeutic effects of cannabis use.Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse.Anandamide in primary sensory neurons: too much of a good thing?mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse.Dissecting the cannabinergic control of behavior: The where matters.Role of nucleus accumbens μ opioid receptors in the effects of morphine on ERK1/2 phosphorylation.
P2860
Q21129371-554F0105-78A8-46AC-8356-DBE0D15D85FFQ24626361-6E513113-74DA-4D19-A13F-FF7E38BE87FEQ24628837-4188D159-C40B-4218-9B71-75BDA82CBB4EQ28392093-965472E7-BFD7-4D4D-BB64-D87CEC5848D2Q28568735-10B0E44A-4B20-4527-B5DE-7E7AFCAE7139Q30276962-33759F09-AC7D-4044-8801-2CC871FE3155Q30499515-7805AB7A-162F-4742-A54E-830E8FB8FD60Q33235276-24ACF35B-CFD4-4BAA-8CCF-7CD0EAF0F426Q33579540-0B5A5601-DA6F-4607-864E-87AEFEBDBEB7Q33723743-C4BC2504-FFDC-477E-8149-63EA8BCCA1AAQ33805049-D3323E15-1855-4355-A061-CF42AFD5446DQ34267133-79BC236F-EADB-4B1A-8970-546894B28258Q34479672-7F4FF12C-9DCC-4AAF-AE2C-BE25FD7CE861Q34483998-213DFA2C-207B-4060-BFBF-2E5649F15861Q34630295-FAAE113F-423A-4A54-84A8-0F5398003587Q34926928-61B89061-662A-403D-81C1-3A54120E5FEFQ35142862-2C83E452-674B-4CCB-AD09-FC4AE78A75DFQ35193273-938F2837-9421-4487-B9C2-162852A5CA78Q35575588-AAC93A9A-725B-40F8-8A64-4194F5E94CEEQ35650688-867BFF59-ED9D-4436-BB44-762F3531C5D4Q35714062-C5077F2D-7159-4DF3-AB11-DE05451310F7Q35841051-47091DB5-E0B6-426F-809A-9919DAE65B84Q35843412-D76C8B5F-4400-4EF4-B363-A0BE840E7667Q35989527-7CD18DDA-1BCF-4640-91D5-B005D2873880Q36012516-658C05CC-B849-4767-9214-9D4E2E7EE976Q36109347-D1DDBFB5-DCC3-4A0A-9056-A858D9695A80Q36514515-4778A14A-C68E-4A1C-94DE-D70CAE0EFB07Q36634045-DBE890C7-37AD-4B40-B713-07DB154CB3D0Q36793931-D51FBE2F-0CEC-42BA-AE12-5630CDD64CF7Q37142233-D3E46008-4DDF-43F2-95E9-27745BB10690Q37470412-B96ECED3-B940-432D-9161-0D73B65C07ABQ37671995-EEBACE4B-0CD9-4EC9-BCAB-1F3C2D86DC03Q37760048-5FBE8816-53BC-4492-AB6F-7D66BEF4B0F4Q37903674-0D6D60C2-5253-4428-8534-CC9E78A77D96Q38039423-DF020A50-B3C4-4545-B309-E221C1DC19BDQ38177261-CE856DE2-5CF2-4AA3-B454-54D1D44973E0Q38185073-2828412C-D206-48AD-A072-A61AC452E6A0Q38199194-D39B54FD-1836-4836-AEA9-D0178BDEC2FCQ38564008-13BC7DB6-A07A-41F8-B262-1E2F01C98249Q38860272-DAC6E70A-9FD6-4BBE-8776-2191D6B5262F
P2860
Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Delta 9-tetrahydrocannabinol-i ...... on dopaminergic transmission.
@en
Delta 9-tetrahydrocannabinol-i ...... on dopaminergic transmission.
@nl
type
label
Delta 9-tetrahydrocannabinol-i ...... on dopaminergic transmission.
@en
Delta 9-tetrahydrocannabinol-i ...... on dopaminergic transmission.
@nl
prefLabel
Delta 9-tetrahydrocannabinol-i ...... on dopaminergic transmission.
@en
Delta 9-tetrahydrocannabinol-i ...... on dopaminergic transmission.
@nl
P2093
P2860
P921
P1476
Delta 9-tetrahydrocannabinol-i ...... s on dopaminergic transmission
@en
P2093
P2860
P304
P356
10.1046/J.0953-816X.2001.01652.X
P407
P577
2001-07-01T00:00:00Z